
    
      A series of sites from outside the US, where the Edwards-Sapien and CoreValve devices are
      approved for commercial sale and implantation, will be recruited to retrospectively identify
      and extract in-hospital data of a patient who underwent TAVI during a live or video-taped
      procedure and a matched patient who underwent TAVI without transmission of the procedure.
    
  